Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
Zynerba Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 21, 2021
Zynerba Pharmaceuticals reported fiscal year 2020 executive compensation information on April 21, 2021.
In 2020, three executives at Zynerba Pharmaceuticals received on average a compensation package of $1.2M, a 8% increase compared to previous year.
Average pay of disclosed executives at Zynerba Pharmaceuticals
Armando Anido, Chief Executive Officer, received $1.5M in total, which increased by 8% compared to 2019. 39% of Anido's compensation, or $585K, was in salary. Anido also received $263K in non-equity incentive plan, $581K in option awards, as well as $53K in other compensation.
Terri B. Sebree, President, received a compensation package of $1.1M, which increased by 7% compared to previous year. 40% of the compensation package, or $451K, was in salary.
James E. Fickenscher, Chief Financial Officer, earned $887K in 2020, a 8% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 21, 2021.